Status:
TERMINATED
A Study of LY3463251 in Healthy Participants
Lead Sponsor:
Eli Lilly and Company
Conditions:
Healthy
Eligibility:
All Genders
18-65 years
Phase:
PHASE1
Brief Summary
The purpose of this study is to evaluate the safety and tolerability (side effects) of single (Part A) and multiple (Part B) doses of the study drug when it is administered subcutaneously (under the s...
Eligibility Criteria
Inclusion
- Healthy males and females
Exclusion
- Diagnosed with Type 1 or Type 2 diabetes
- Women who are of childbearing potential or who are breastfeeding
- Donated blood of more than 500 millilitres (mL) within the previous 3 months of study screening
- Have used any tobacco product within 3 months of Day -1, or are unwilling to refrain from the use of tobacco during the study
Key Trial Info
Start Date :
December 6 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 7 2020
Estimated Enrollment :
118 Patients enrolled
Trial Details
Trial ID
NCT03764774
Start Date
December 6 2018
End Date
December 7 2020
Last Update
November 4 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Covance Clinical Research Inc
Daytona Beach, Florida, United States, 32117